Coldstream Capital Management’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Coldstream Capital Management's AGL Position: Q2 2025 in Review
Coldstream Capital Management sold out of Agilon Health (AGL) in Q2 2025, closing a stake of 70 shares — an estimated $7.55K sold.
Coldstream Capital Management first reported a position in AGL in Q1 2025 and held it in 1 quarter. The position peaked at $7.55K in Q1 2025. 205 funds tracked by Wall St. Rank hold AGL as of Q2 2025.
- Coldstream Capital Management reported no remaining Agilon Health position as of Q2 2025 after selling out during the quarter.
- Coldstream Capital Management sold 70 Agilon Health shares in Q2 2025, an estimated $7.55K.
- Coldstream Capital Management first reported a position in Agilon Health in Q1 2025 and held it in 1 quarter.
- Coldstream Capital Management's Agilon Health position peaked at $7.55K in Q1 2025.
- 205 funds tracked by Wall St. Rank held Agilon Health as of Q2 2025.
Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.